Patrick R. Harrington

2.5k total citations
33 papers, 1.8k citations indexed

About

Patrick R. Harrington is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Patrick R. Harrington has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 14 papers in Epidemiology and 12 papers in Hepatology. Recurrent topics in Patrick R. Harrington's work include Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (9 papers). Patrick R. Harrington is often cited by papers focused on Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (9 papers). Patrick R. Harrington collaborates with scholars based in United States, France and United Kingdom. Patrick R. Harrington's co-authors include Christine L. Moe, Ralph S. Baric, Lisa K. Naeger, Boyd L. Yount, Lisa C. Lindesmith, Ronald Swanstrom, Julian J. O’Rear, Eric Donaldson, Takashi Komatsu and Robert E. Johnston and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Patrick R. Harrington

32 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick R. Harrington United States 21 1.1k 722 538 494 287 33 1.8k
Monica M. Parker United States 21 1.1k 1.0× 692 1.0× 302 0.6× 351 0.7× 244 0.9× 53 1.7k
Steve Kaye United Kingdom 30 1.3k 1.2× 1.1k 1.5× 278 0.5× 1.2k 2.4× 28 0.1× 83 2.8k
Christopher Payan France 24 571 0.5× 885 1.2× 652 1.2× 85 0.2× 73 0.3× 70 1.7k
Benjamin Lee United States 20 453 0.4× 366 0.5× 113 0.2× 43 0.1× 75 0.3× 44 1.0k
Hans Gaines Sweden 33 1.5k 1.4× 902 1.2× 105 0.2× 1.7k 3.4× 27 0.1× 61 2.8k
Neil Berry United Kingdom 26 944 0.9× 697 1.0× 38 0.1× 1.2k 2.3× 45 0.2× 89 2.0k
W. Al‐Nakib Kuwait 25 670 0.6× 1.0k 1.4× 224 0.4× 56 0.1× 107 0.4× 100 1.8k
C. J. White United States 20 345 0.3× 1.1k 1.6× 112 0.2× 254 0.5× 248 0.9× 26 1.5k
Frances K. Newman United States 27 705 0.6× 1.5k 2.1× 39 0.1× 836 1.7× 44 0.2× 43 2.8k
Emma Aarons United Kingdom 22 891 0.8× 327 0.5× 27 0.1× 253 0.5× 152 0.5× 49 1.6k

Countries citing papers authored by Patrick R. Harrington

Since Specialization
Citations

This map shows the geographic impact of Patrick R. Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick R. Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick R. Harrington more than expected).

Fields of papers citing papers by Patrick R. Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick R. Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick R. Harrington. The network helps show where Patrick R. Harrington may publish in the future.

Co-authorship network of co-authors of Patrick R. Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick R. Harrington. A scholar is included among the top collaborators of Patrick R. Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick R. Harrington. Patrick R. Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrington, Patrick R., et al.. (2025). Impact of nutritional interventions on quality of life in schizophrenia spectrum disorders: a scoping review. Irish Journal of Psychological Medicine. 42(3). 221–226.
2.
Cortese, Irene, Gina Norato, Patrick R. Harrington, et al.. (2024). Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials. The Lancet Neurology. 23(5). 534–544. 1 indexed citations
3.
Harrington, Patrick R., Stephanie B. Troy, Jonathan Rawson, et al.. (2023). Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials — United States and International Sites, 2021–2022. MMWR Morbidity and Mortality Weekly Report. 72(51). 1365–1370. 10 indexed citations
4.
Chan‐Tack, Kirk M., Patrick R. Harrington, Suyoung Choi, et al.. (2021). Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation. Antiviral Research. 195. 105182–105182. 55 indexed citations
5.
Chan‐Tack, Kirk M., Patrick R. Harrington, Suyoung Choi, et al.. (2019). Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox. The Lancet Infectious Diseases. 19(6). e221–e224. 28 indexed citations
6.
Tracy, LaRee, et al.. (2017). US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection. Clinical Drug Investigation. 37(4). 317–326. 9 indexed citations
7.
Komatsu, Takashi, Adam Sherwat, LaRee Tracy, et al.. (2016). Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir. Gastroenterology. 152(3). 586–597. 42 indexed citations
8.
Harrington, Patrick R., Russell Fleischer, Sarah Connelly, Linda Lewis, & Jeffrey S. Murray. (2015). Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus–Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral Regimens: Figure 1.. Clinical Infectious Diseases. 61(6). 974–977. 7 indexed citations
9.
Lontok, Erik, Patrick R. Harrington, A Howe, et al.. (2015). Hepatitis C virus drug resistance–associated substitutions: State of the art summary. Hepatology. 62(5). 1623–1632. 217 indexed citations
10.
Komatsu, Takashi, Andreas Pikis, Lisa K. Naeger, & Patrick R. Harrington. (2013). Resistance of human cytomegalovirus to ganciclovir/valganciclovir: A comprehensive review of putative resistance pathways. Antiviral Research. 101. 12–25. 57 indexed citations
11.
Florian, Jeffry, Pravin Jadhav, Shashi Amur, et al.. (2012). Boceprevir dosing for late responders and null responders: The role of bridging data between treatment-naïve and -experienced subjects. Hepatology. 57(3). 903–907. 9 indexed citations
12.
Harrington, Patrick R., Wen Zeng, & Lisa K. Naeger. (2011). Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment. Hepatology. 55(4). 1048–1057. 55 indexed citations
13.
Harrington, Patrick R., Gretja Schnell, Scott Letendre, et al.. (2009). Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 23(8). 907–915. 86 indexed citations
14.
Schnell, Gretja, Serena Spudich, Patrick R. Harrington, Richard W. Price, & Ronald Swanstrom. (2009). Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1–Associated Dementia. PLoS Pathogens. 5(4). e1000395–e1000395. 113 indexed citations
15.
Harrington, Patrick R., Mary J. Connell, Rick B. Meeker, Philip R. Johnson, & Ronald Swanstrom. (2007). Dynamics of Simian Immunodeficiency Virus Populations in Blood and Cerebrospinal Fluid over the Full Course of Infection. The Journal of Infectious Diseases. 196(7). 1058–1067. 19 indexed citations
16.
LoBue, Anna D., Lisa C. Lindesmith, Boyd L. Yount, et al.. (2006). Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine. 24(24). 5220–5234. 105 indexed citations
17.
Harrington, Patrick R., David W. Haas, Kimberly Ritola, & Ronald Swanstrom. (2005). Compartmentalized Human Immunodeficiency Virus Type 1 Present in Cerebrospinal Fluid Is Produced by Short-Lived Cells. Journal of Virology. 79(13). 7959–7966. 51 indexed citations
18.
Raw, Martin, Peter Anderson, Anil Batra, et al.. (2002). WHO Europe evidence based recommendations on the treatment of tobacco dependence. Tobacco Control. 11(1). 44–46. 61 indexed citations
19.
Baric, Ralph S., Boyd L. Yount, Lisa C. Lindesmith, et al.. (2002). Expression and Self-Assembly of Norwalk Virus Capsid Protein from Venezuelan Equine Encephalitis Virus Replicons. Journal of Virology. 76(6). 3023–3030. 72 indexed citations
20.
Harrington, Patrick R., Lisa C. Lindesmith, Boyd L. Yount, Christine L. Moe, & Ralph S. Baric. (2002). Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice. Journal of Virology. 76(23). 12335–12343. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026